WEC
TEVA icon

Winslow Evans & Crocker’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Winslow Evans & Crocker’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-50
Closed -$2K – 1171
2020
Q1 		$2K Buy
+50
New +$512 ﹤0.01% 1064
2016
Q4 		– Sell
-488
Closed -$22.4K – 1314
2016
Q3 		$22.4K Sell
488
-300
-38% -$15.7K 0.01% 708
2016
Q2 		$39.5K Buy
788
+1
+0.1% +$53 0.01% 570
2016
Q1 		$42.1K Sell
787
-131
-14% -$7.69K 0.01% 543
2015
Q4 		$60.3K Sell
918
-226
-20% -$14K 0.02% 496
2015
Q3 		$64.5K Buy
1,144
+226
+25% +$14.7K 0.02% 470
2015
Q2 		$54.3K Hold
918
– – 0.02% 534
2015
Q1 		$57.2K Sell
918
-136
-13% -$7.91K 0.02% 521
2014
Q4 		$60.6K Buy
1,054
+84
+9% +$4.68K 0.02% 503
2014
Q3 		$52.1K Sell
970
-44
-4% -$2.33K 0.01% 546
2014
Q2 		$53.2K Buy
1,014
+517
+104% +$26.4K 0.02% 486
2014
Q1 		$26.3K Sell
497
-31
-6% -$1.43K 0.01% 611
2013
Q4 		$21K Buy
+528
New +$20.8K 0.01% 691

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Evans & Crocker's TEVA Position: Q2 2020 in Review

Winslow Evans & Crocker sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2020, closing a stake of 50 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in TEVA in Q4 2013 and held it in 13 quarters. The position peaked at $64.5K in Q3 2015. 456 funds tracked by Wall St. Rank hold TEVA as of Q2 2020.

  • Winslow Evans & Crocker reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2020 after selling out during the quarter.
  • Winslow Evans & Crocker sold 50 Teva Pharmaceutical Industries Limited shares in Q2 2020, an estimated $2K.
  • Winslow Evans & Crocker first reported a position in Teva Pharmaceutical Industries Limited in Q4 2013 and held it in 13 quarters.
  • Winslow Evans & Crocker's Teva Pharmaceutical Industries Limited position peaked at $64.5K in Q3 2015.
  • 456 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2020.

Based on Winslow Evans & Crocker's 13F filing for Q2 2020, filed 23 Jul 2020.